Table 1. Impacts of tobacco smoking on each transition in cardiometabolic diseases.
| Numbers of events | HR (95%CI) | |
| Cardiometabolic diseases include IHD, IS, HS, and T2DM. CMM was defined as the occurrence of at least two of the above-mentioned diseases. Multivariable models were stratified by age in the 5-year interval, study area, and adjusted for sex, education, marital status, parental family history of CMM. CMM: cardiometabolic multimorbidity; FCMD: first cardiometabolic disease; HS: haemorrhagic stroke; IHD: ischemic heart disease; IS: ischemic stroke; T2DM: type 2 diabetes mellitus. | ||
| Baseline→ FCMD | ||
| Baseline→ IHD | 34,304 | 1.23 ( 1.19 – 1.27 ) |
| Baseline→ IS | 31,012 | 1.14 ( 1.10–1.18 ) |
| Baseline→ HS | 6,715 | 0.99 (0.92–1.05) |
| Baseline→ T2DM | 14,215 | 0.98 (0.93–1.04) |
| FCMD→ CMM | ||
| IHD→ CMM | 5,507 | 1.04 (0.97–1.13) |
| IS→ CMM | 5,968 | 1.06 (0.99–1.14) |
| HS→ CMM | 1,088 | 0.82 (0.68–0.99) |
| T2DM→ CMM | 2,094 | 1.21 ( 1.07–1.38) |
| Baseline→ Death | 19,852 | 1.40 ( 1.35–1.45) |
| FCMD→ Death | ||
| IHD→ Death | 5,819 | 1.26 ( 1.18–1.36) |
| IS→ Death | 3,107 | 1.28 ( 1.17–1.41) |
| HS→ Death | 3,671 | 1.05 (0.95–1.16) |
| T2DM→ Death | 776 | 1.38 ( 1.13–1.68) |
| CMM→ Death | 3,810 | 1.19 ( 1.10–1.30) |